Juan Gagliardi
Grupo México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Juan Gagliardi.
Journal of Cardiac Failure | 2011
Javier Mariani; Alejandro Macchia; César Belziti; Maximiliano DeAbreu; Juan Gagliardi; Hernán C. Doval; Gianni Tognoni; Carlos D. Tajer
BACKGROUND The evidence of individual studies in acute cardiogenic pulmonary edema (ACPE) supporting noninvasive ventilation (NIV) is still inconclusive, particularly regarding noninvasive positive pressure ventilation (NIPPV). METHODS We carried out a meta-analysis. We searched in the Embase, Medline, Cinahl, Dare, Coch, Central, and CNKI databases and congress abstracts for trials comparing continuous positive airway pressure (CPAP) or NIPPV with standard therapy (ST). To assess treatment effects, we carried out direct comparison using a random effects model and adjusted indirect comparison. RESULTS At total of 34 studies (3,041 patients) were included. In direct comparisons, both CPAP and NIPPV reduced the risk of death (relative risk [RR] 0.64, 95% CI 0.44-0.93; RR 0.80, 95% CI 0.58-1.10; respectively) compared with ST, although only CPAP had a significant effect. There were no significant differences between NIPPV and CPAP. Pooled results of direct and adjusted indirect comparisons showed that compared with ST, both CPAP and NIPPV significantly reduced mortality (RR 0.63, 95% CI 0.44-0.89; RR 0.73, 95% CI 0.55-0.97; respectively). CONCLUSIONS Our findings suggest that among ACPE patients, NIV delivered through either NIPPV or CPAP reduced mortality.
Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2013
María Cristina Saccheri; Tomás F. Cianciulli; Jorge A. Lax; Juan Gagliardi; Guillermo Cáceres; Alejandra E. Quarin; Isaac Kisinovsky; Paula Rozenfeld; Ricardo Reisin
Fabry disease (FD) is characterized by left ventricular hypertrophy (LVH). Conventional echocardiography is not sensitive enough to perform the preclinical diagnosis To assess whether longitudinal myocardial strain of the left ventricle (LV), using speckle tracking, is useful to detect early myocardial involvement in FD. Forty‐four patients with FD who were diagnosed with genetic testing were prospectively included and were compared to a sex‐matched control group. They were divided into three groups: 22 with LVH (Group I), 22 without LVH (Group II), and 22 healthy volunteers (Group III). LV longitudinal strain was measured from the apical views. An ANOVA test was used for multiple comparisons for variables with a normal distribution, and a Kruskal–Wallis test was used for variables with non‐Gaussian distribution. Longitudinal LV strain was different in the three groups: it was ≥−15% in at least one segment in all Group I patients, in 50% of patients of Group II and in no patient of Group III. Seventy percent of the segments with abnormal strain in Group II were located in the basal regions (32/46). These findings show that the presence of at least one strain value ≥−15% demonstrates subclinical myocardial dysfunction in patients with preclinical FD. Longitudinal myocardial LV strain measured with speckle tracking is a useful tool to detect early myocardial involvement in young patients with FD. This information allows the detection and treatment of myocardial dysfunction at an early stage, which is of high clinical importance.
BMC Cardiovascular Disorders | 2003
Alfredo Piombo; Juan Gagliardi; Javier Guetta; Juan J. Fuselli; Simón Salzberg; Enrique Fairman; Carlos A. Bertolasi
BackgroundWe performed this study to develop a new scoring system to stratify different levels of risk in patients admitted to hospital with a diagnosis of unstable angina (UA), which is a complex syndrome that encompasses different outcomes. Many prognostic variables have been described but few efforts have been made to group them in order to enhance their individual predictive power.MethodsIn a first phase, 473 patients were prospectively analyzed to determine which factors were significantly associated with the in-hospital occurrence of refractory ischemia, acute myocardial infarction (AMI) or death. A risk score ranging from 0 to 10 points was developed using a multivariate analysis. In a second phase, such score was validated in a new sample of 242 patients and it was finally applied to the entire population (n = 715).ResultsST-segment deviation on the electrocardiogram, age ≥ 70 years, previous bypass surgery and troponin T ≥ 0.1 ng/mL were found as independent prognostic variables. A clear distinction was shown among categories of low, intermediate and high risk, defined according to the risk score. The incidence of the triple end-point was 6 %, 19.2 % and 44.7 % respectively, and the figures for AMI or death were 2 %, 11.4 % and 27.6 % respectively (p < 0.001).ConclusionsThis new scoring system is simple and easy to achieve. It allows a very good stratification of risk in patients having a clinical diagnosis of UA. They may be divided in three categories, which could be of help in the decision-making process.
Psychoneuroendocrinology | 2016
Nahuel Fernandez Machulsky; Juan Gagliardi; Bibiana Fabre; Verónica Miksztowicz; Micaela Lombardo; Alejandro García Escudero; Gerardo Gigena; Federico Blanco; Ricardo J. Gelpi; Laura Schreier; Yori Gidron; Gabriela Berg
UNLABELLED Psychosocial factors have been linked to cardiovascular diseases independently of traditional risk factors. The impact of psychosocial factors on plaque destabilizing factors, such as matrix metalloproteinases (MMPs) has been proposed although scarcely studied. OBJECTIVE To evaluate the relationships between hostility, perceived stress and social support with MMPs activity in patients after an Acute Myocardial Infarction (AMI). METHODS Blood samples were obtained from 76 patients on admission, post-angioplasty, 24h, 7 days and 3 months after AMI. Hostility, perceived stress and social support were evaluated by validated questionnaires. RESULTS Social support was positively correlated with patientś ejection fraction (r=0.453, p=0.009). Patients with higher infarct size presented increased MMP-2 activity at admission (p=0.04). Patients with one diseased vessel had more social support than those with three diseased vessels (p=0.05). The highest values of MMP-2 and MMP-9 activity were observed at the acute event, decreasing, with the lowest activity at 3 months post-AMI (p<0.001). Only in patients with low social support, hostility correlated with MMP-2 activity, from AMI onset (r=0.645, p=0.013), to 7 days post AMI (r=0.557, p=0.038). Hostility explained up to 28% of the variance in MMP-2 activity (R(2)=0.28, p=0.005). Finally, in patients with high hostility, MMP-9 was positively correlated with IL-1β (r=0.468, p=0.02). CONCLUSIONS This study adds weight to the idea that two psychosocial factors, namely hostility and social support, acting jointly, may affect MMP-2 activity. Moreover, in hostile patients, there is a link between IL-1β and MMP-9. These findings support the role of psychosocial factors in plaque destabilization and in the inflammatory process in AMI.
Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2013
Daniel Ernesto Ferreiro; Tomás F. Cianciulli; María Cristina Saccheri; Jorge A. Lax; Leonardo Celano; Martín Alejandro Beck; Juan Gagliardi; Lucía R. Kazelian; Roberto Neme
Recent advances in echocardiography have allowed assessment of flow velocity in the epicardial coronary arteries of patients with ischemic heart disease, using transthoracic color Doppler echocardiography (TTDE). However, few data are available regarding coronary blood flow in patients with hypertrophic cardiomyopathy (HCM).
Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2018
María Cristina Saccheri; Tomás F. Cianciulli; Wilde Challapa Licidio; Jorge A. Lax; Martín Alejandro Beck; Luis A. Morita; Juan Gagliardi; Aadelfa
Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) are two diseases with a different pathophysiology, both cause left ventricular hypertrophy (LVH) and myocardial fibrosis. Although remodeling and systolic dysfunction of the left atrium (LA) are associated with atrial fibrillation and stroke in HCM, changes in the size and function of the LA have not been well studied in FD with LVH.
Current Vascular Pharmacology | 2017
Nahuel Fernandez Machulsky; Magalí Barchuk; Juan Gagliardi; Diego Gonzalez; Micaela Lombardo; Alejandro García Escudero; Gerardo Gigena; Federico Blanco; Laura Schreier; Bibiana Fabre; Gabriela Berg
BACKGROUND Vitamin D is a fat soluble vitamin involved in calcium and bone metabolism; recently its deficiency has been related to cardiovascular disease. In cardiac tissue, vitamin D suppresses metalloproteinases (MMPs) expression, enzymes directly associated with vulnerable plaque. OBJECTIVE To investigate whether the association between vitamin D and leptin is related to markers of vulnerable plaque, such as MMPs in patients with acute myocardial infarction. METHODS We studied 66 male patients with acute myocardial infarction, undergoing primary angioplasty. Blood samples were obtained at admission and 24hs after the surgery. Leptin and vitamin D concentrations in serum and MMP-2 and -9 activities in plasma were determined. RESULTS MMP-2 activity was increased in Vitamin D deficient/insufficient patients at admission (p=0.04) and 24 hs later (p=0.05). In a linear regression model, vitamin D explained 24% of the variance of MMP-2 activity (F=2.839 p=0.04). At admission, vitamin D correlated with serum leptin (r=-0.302 p=0.033), and explained 39.5% of its variation (F=4.432 p=0.003). CONCLUSION In the studied population, vitamin D was inversely related to MMP-2 and leptin which are involved in coronary artery disease and acute myocardial infarction. The decrease in this hormone levels would be associated with a worse metabolic profile in acute coronary syndrome patients.
Heart Lung and Circulation | 2017
Ricardo Sarmiento; Rodrigo Blanco; Gerardo Gigena; Jorge A. Lax; Alejandro García Escudero; Federico Blanco; Jorge Szarfer; Raúl Solernó; Carlos D. Tajer; Juan Gagliardi
BACKGROUND Percutaneous balloon mitral valvuloplasty (PMV) is an attractive therapeutic approach in patients with mitral stenosis. The aim of this study was to assess the immediate and long-term clinical, echocardiographic and haemodynamic outcomes of PMV in patients with severe pulmonary hypertension (PAH). METHODS Percutaneous balloon mitral valvuloplasty was performed in 157 consecutive patients; 60 patients (38.2%) had significant PAH defined as baseline pulmonary artery mean pressure (PAMP) ≥ 30mm Hg (Group 1) and 97 patients (61.8%) had PAMP ≤ 30mmHg (Group 2). Pulmonary artery systolic pressure (PASP), mortality, need for mitral valve replacement or new PMV, and valve restenosis were evaluated during follow-up. RESULTS Mean age was 44.2 years and 88.5% (139 patients) were women. Primary success was achieved in 79.6% of the patients (125 patients) without differences between the groups. Mitral valve area increased from 0.90cm2 to 1.76cm2, PASP fell from 57mmHg to 35mmHg in Group 1 and from 38mmHg to 30mmHg in Group 2. Median PASP in Group 1 was 35, 32, 36, 38 and 34mmHg at 12, 24, 36, 48 and 60 months. There were no significant differences in mitral valve area, PASP and clinical status between the groups. CONCLUSION Percutaneous balloon mitral valvuloplasty is a safe and effective technique for the treatment of patients with mitral stenosis and PAH. A significant decrease in pulmonary pressure was observed after valvuloplasty. Although there was a gradual decrease of MVA at long-term follow-up, most patients remained asymptomatic and PASP was stable.
Argentine Journal of Cardiology | 2017
Juan Gagliardi; Adrián Charask; Eduardo R. Perna; Heraldo D'Imperio; Julio O. Bono; Yanina Castillo Costa; Gustavo H. Cerezo; Carlos D. Tajer
Background: ST-segment elevation acute myocardial infarction (STEMI) is one of the most challenging pathologies for the health system; therefore, it is necessary to have a registry with suitably accurate information to adopt public policies and guidelines adjusted to national needs. The Argentine Society of Cardiology (SAC) and the Argentine Federation of Cardiology (FAC) are carrying out a national registry (ARGEN-IAM-ST) that aims to comprise the “universe” of STEMI treatment. Objective: The purpose of this study was to evaluate, as broadly as possible, clinical aspects, delays, treatment strategies and outcomes, as well as eventual barriers that need improvement in STEMI care. Methods: The study included 1,759 patients in 247 centers throughout the country between March and December 2015. Results: Among all patients, 83.5% received reperfusion treatment, and in 78.3% of cases, this was performed by primary angioplasty. Thirty-seven per cent of patients were admitted from another institution, but only 16% of them received fibrinolytic therapy prior to referral. Door-to-needle time was ≤30 minutes in only 25% of patients receiving fibrinolytic agents and door-to-balloon time was ≤90 minutes in 47.7% of patients treated with angioplasty. In-hospital mortality was 8.8%. Conclusions: These data allow delineating a map of acute myocardial infarction in Argentina. Delays in treatment are important and there are aspects to correct. These data suggest the need to implement corrective strategies, such as the application of medical education programs, supportive health policies, considering regional characteristics and on-site cost/benefit of reperfusion strategies, which might help to shorten time to reperfusion, both for thrombolytic therapy as for primary angioplasty.
Thrombosis Research | 2016
Juan Gagliardi; Neiva Maciel; José Luis Castellano; Osvaldo H. Masoli; Verónica Miksztowicz; Gabriela Berg; Emilse Bermejo; Maria A. Lazzari; Ricardo J. Gelpi
BACKGROUND The aim of our study was to evaluate the effect of programmed physical activity and a single exercise test on the number of CD309+ circulating endothelial progenitor cell (EPC) and their relation to the variation in plasma levels of VEGF in chronic coronary patients. METHODS 21 patients <75 years with chronic stable coronary artery disease were included. All patients underwent exercise myocardial perfusion SPECT. Then, participants were divided into two groups: one group (11 patients) underwent cardiac rehabilitation program and the other (10 patients) continued with the standard treatment. Blood samples were obtained at baseline, 30 min after exercise ended and at one and three months during follow-up. RESULTS VEGF values decreased significantly after exercise SPECT test. After one month, there was a significant increase in VEGF levels compared to those measured immediately after exercise. All patients showed a decrease in the values of EPC at 1 and 3-month follow-up. There was an inverse and statistically significant relation between change of EPC and VEGF between the baseline and 1 month. CONCLUSIONS The increase of VEGF at 1-month, with respect to baseline values correlated with decreased levels of EPC. This association was independent of the onset of ischemia in the perfusion study.